B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Daniela Asslaber (First author), Yuan Qi, Nicole Maeding, Markus Steiner (Co-author), Ursula Denk (Co-author), Jan Philip Höpner, Tanja Hartmann (Co-author), Nadja Zaborsky (Co-author), Richard Greil (Co-author), Alexander Egle* (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

17 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1729
JournalBLOOD
Volume134
Issue number20
DOIs
Publication statusPublished - 2019

Keywords

  • TRANSGENIC MOUSE MODEL
  • DENDRITIC CELLS
  • ACTIVATION
  • EXPRESSION
  • CLL
  • SUPPRESSOR
  • GENERATION
  • MUTATIONS
  • BETA

Cite this